• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物流行病学中的健康用户效应。

The Healthy User Effect in Pharmacoepidemiology.

作者信息

Olawore Oluwasolape, Stϋrmer Til, Glynn Robert J, Lund Jennifer L

机构信息

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

出版信息

Am J Epidemiol. 2024 Sep 11. doi: 10.1093/aje/kwae358.

DOI:10.1093/aje/kwae358
PMID:39270671
Abstract

The healthy user effect is a well-recognized bias in the field of pharmacoepidemiology and can be expected to overstate the effect of a preventive intervention when comparing long term users or "adherers" to non-users. Similar to the healthy worker effect observed in occupational epidemiology, the healthy user effect can be separated into a healthy initiator effect (baseline confounding) and a healthy adherer effect (selection bias). Restriction approaches and new user designs that implicitly condition on the indication and, similar healthy behaviors or health status can often mitigate the healthy initiator effect (confounding) or healthy adherer effect (selection bias) at the start of a study. Addressing the healthy adherer effect due to continued conditioning on adherence over the duration of a study is more challenging as methods to mitigate it require the ability to predict adherence, which is often difficult using databases common in pharmacoepidemiologic research. Here, we describe the healthy user effect, with supporting examples, and describe study design approaches available to pharmacoepidemiologists to mitigate the potential for bias.

摘要

健康使用者效应是药物流行病学领域中一种广为人知的偏差,在比较长期使用者或“依从者”与非使用者时,预计会高估预防性干预措施的效果。与职业流行病学中观察到的健康工人效应类似,健康使用者效应可分为健康启动者效应(基线混杂)和健康依从者效应(选择偏倚)。限制方法和新使用者设计,即隐含地以适应症以及类似的健康行为或健康状况为条件,通常可以在研究开始时减轻健康启动者效应(混杂)或健康依从者效应(选择偏倚)。由于在研究过程中持续以依从性为条件而产生的健康依从者效应更具挑战性,因为减轻这种效应的方法需要具备预测依从性的能力,而使用药物流行病学研究中常见的数据库往往很难做到这一点。在此,我们通过支持性示例描述健康使用者效应,并描述药物流行病学家可采用的研究设计方法,以减轻偏差的可能性。

相似文献

1
The Healthy User Effect in Pharmacoepidemiology.药物流行病学中的健康用户效应。
Am J Epidemiol. 2024 Sep 11. doi: 10.1093/aje/kwae358.
2
Initiator Types and the Causal Question of the Prevalent New-User Design: A Simulation Study.启动器类型与流行的新用户设计的因果问题:一项模拟研究。
Am J Epidemiol. 2021 Jul 1;190(7):1341-1348. doi: 10.1093/aje/kwaa283.
3
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators.药物流行病学的核心概念:指示性混杂和活性对照物的作用。
Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):261-269. doi: 10.1002/pds.5407. Epub 2022 Jan 27.
4
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.药物流行病学中的活性对照、新用户研究设计:历史基础与当代应用。
Curr Epidemiol Rep. 2015 Dec;2(4):221-228. doi: 10.1007/s40471-015-0053-5. Epub 2015 Sep 30.
5
The importance and implications of comparator selection in pharmacoepidemiologic research.药物流行病学研究中对照选择的重要性及影响
Curr Epidemiol Rep. 2018 Sep;5(3):272-283. doi: 10.1007/s40471-018-0155-y. Epub 2018 Jul 6.
6
New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.新用户和普遍用户设计以及药物流行病学中研究时间起点的定义:报告实践综述。
Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):960-974. doi: 10.1002/pds.5258. Epub 2021 May 10.
7
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.药物流行病学的核心概念:药物流行病学研究中出现的主要偏倚。
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):9-18. doi: 10.1002/pds.5547. Epub 2022 Oct 20.
8
Invited Commentary: The Prevalent New-User Design in Pharmacoepidemiology-Challenges and Opportunities.特邀评论:药物流行病学中新用户设计的普遍趋势——挑战与机遇。
Am J Epidemiol. 2021 Jul 1;190(7):1349-1352. doi: 10.1093/aje/kwaa284.
9
Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.极端限制设计作为一种在药物流行病学研究中减少混杂偏倚的方法。
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:26-34. doi: 10.1002/pds.4708. Epub 2019 Jan 9.
10
Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.观察性研究中预防干预措施的健康使用者和相关偏倚:医生指南。
J Gen Intern Med. 2011 May;26(5):546-50. doi: 10.1007/s11606-010-1609-1. Epub 2011 Jan 4.

引用本文的文献

1
Estimating cardiovascular effects of influenza vaccination in older adults: a target trial emulation using proximal causal inference.评估老年人流感疫苗接种的心血管效应:使用近端因果推断进行目标试验模拟。
EClinicalMedicine. 2025 Aug 21;87:103449. doi: 10.1016/j.eclinm.2025.103449. eCollection 2025 Sep.
2
Impact of Hospital Volume on In-Hospital Cardiac Arrest Mortality: Trends Before and During the COVID-19 Pandemic.医院规模对院内心脏骤停死亡率的影响:COVID-19大流行之前及期间的趋势
Cureus. 2025 Jul 11;17(7):e87743. doi: 10.7759/cureus.87743. eCollection 2025 Jul.
3
Lichen Planus Following COVID-19 Infection and Vaccination. Matched Case-Control Study.
新型冠状病毒肺炎感染和疫苗接种后扁平苔藓。配对病例对照研究。
Australas J Dermatol. 2025 Aug;66(5):289-295. doi: 10.1111/ajd.14522. Epub 2025 May 5.